MedDataX Logo

German MPN-Registry for BCR-ABL 1-Negative Myeloid Neoplasms (Study Group Ulm)

NCT ID: NCT03125707

Last Updated: 2023-05-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

2172 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-05-31

Study Completion Date

2045-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To register a large number of patients with the diagnosis of a BCR-ABL 1- negative myeloid neoplasm (according to WHO 2008 / 2016 classification) in participating centers

To store samples from all patients (e.g. bone marrow aspirate, peripheral blood, plasma, and buccal swap, skin biopsy samples in exceptional cases)

To perform morphologic and genetic analyses

To assess clinical characteristics and outcome data using a defined catalogue containing clinically relevant variables

To assess biological disease features and correlate with clinical outcome data (prognostic and predictive markers)

To assess quality of life

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Multicenter Tissue Registry in Melanoma

NCT05750511

Metastatic Melanoma
UNKNOWN

Regional Central Database Recording of Chronic Myeloid Leukemia

NCT02869256

Chronic Myeloid Leukemia
UNKNOWN

Registry of the German CLL Study Group

NCT02863692

CLL SLL HCL +5 more
RECRUITING

Integrated Multiomics and Multilevel Characterization of Haematological Disorders and Malignancies

NCT04298892

Haematologic Disease Haematological Malignancy
UNKNOWN

Establishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies

NCT00131014

Non-Hodgkin's Lymphoma Hodgkin's Disease Leukemia, Lymphocytic, Chronic +1 more
RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

To register a large number of patients with the diagnosis of a BCR-ABL 1- negative myeloid neoplasm (according to WHO 2008 / 2016 classification) in participating centers

To store samples from all patients (e.g. bone marrow aspirate, peripheral blood, plasma, and buccal swap, skin biopsy samples in exceptional cases)

To perform morphologic and genetic analyses

To assess clinical characteristics and outcome data using a defined catalogue containing clinically relevant variables

To assess biological disease features and correlate with clinical outcome data (prognostic and predictive markers)

To assess quality of life

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

BCR-ABL1-Negative Myeloid Neoplasms

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Registry study

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with BCR-ABL 1-myeloid neoplasia according to WHO classification or IWG MRI criteria
* Age ≥ 18 years. There is no upper age limit.
* Signed written informed consent.

Exclusion Criteria

* Severe neurological or psychiatric disorder interfering with ability to give an informed consent
* No consent for registration, storage and handling of the personal data
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Ulm

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Frank Stegelmann

Principal Investigator Dr. med.

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hämatologische Onkologie Praxis Augsburg

Augsburg, , Germany

Site Status RECRUITING

Klinikum Augsburg

Augsburg, , Germany

Site Status RECRUITING

Helios Klinikum, Bad Saarow

Bad Saarow, , Germany

Site Status RECRUITING

Klinikum Mittelbaden

Baden-Baden, , Germany

Site Status RECRUITING

MVZ Klinikum Coburg

Coburg, , Germany

Site Status RECRUITING

Donauwörth, Onko-Medeor

Donauwörth, , Germany

Site Status RECRUITING

Onkologie, BAG, Dresden

Dresden, , Germany

Site Status RECRUITING

Onkologie Erding

Erding, , Germany

Site Status RECRUITING

Universitätsklinikum Freiburg

Freiburg im Breisgau, , Germany

Site Status RECRUITING

Alb Fils Kliniken Göppingen

Göppingen, , Germany

Site Status RECRUITING

Universitätsklinikum Greifswald

Greifswald, , Germany

Site Status RECRUITING

Onkologische Praxis, Heidelberg

Heidelberg, , Germany

Site Status WITHDRAWN

Onkologische Schwerpunktpraxis, Heilbronn

Heilbronn, , Germany

Site Status WITHDRAWN

Marienhospital Bochum-Herne

Herne, , Germany

Site Status RECRUITING

Universitätsklinikum Jena

Jena, , Germany

Site Status RECRUITING

Klinikum Kempten-Oberallgäu gGmbH

Kempten, , Germany

Site Status RECRUITING

Landshut VK&K Studien GbR

Landshut, , Germany

Site Status RECRUITING

Leer, Studienzentrum Unter Ems

Leer, , Germany

Site Status ACTIVE_NOT_RECRUITING

Universitätsklinikum Leipzig

Leipzig, , Germany

Site Status RECRUITING

Universitätsklinikum Magdeburg

Magdeburg, , Germany

Site Status RECRUITING

Universitätsklinikum Mannheim

Mannheim, , Germany

Site Status RECRUITING

Mannheim, Onkologiepraxis

Mannheim, , Germany

Site Status RECRUITING

Memmingen, Onkologiepraxis

Memmingen, , Germany

Site Status RECRUITING

Mühlenkreiskliniken Minden

Minden, , Germany

Site Status RECRUITING

Stauferklinikum Schwäbisch Gmünd

Mutlangen, , Germany

Site Status RECRUITING

Diakonie-Klinikum Stuttgart

Stuttgart, , Germany

Site Status RECRUITING

Stuttgart, MVZ am RBK

Stuttgart, , Germany

Site Status RECRUITING

Universitätsklinikum Ulm

Ulm, , Germany

Site Status RECRUITING

Rems-Murr-Kliniken Winnenden

Winnenden, , Germany

Site Status RECRUITING

Würzburg / Kitzingen, Gemeinschaftspraxis Dr. Schlag

Würzburg, , Germany

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Germany

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Frank Stegelmann, Dr.

Role: CONTACT

[email protected]
+4973150045521

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Markus Bangerter, MD

Role: primary

[email protected]
+498213446520

Klaus Hirschbühl, MD

Role: primary

[email protected]
+498214003715

Daniel Schöndube, MD

Role: primary

[email protected]
+493363173728

Jutta Hagemeyer, MD

Role: primary

[email protected]
+497221/91-4126

Christof Lamberti, MD

Role: primary

[email protected]
+49956122-34607

Dirk Hempel, MD

Role: primary

[email protected]
+49906299939-0

Thomas Illmer, MD

Role: primary

[email protected]
+493514400022

Stefanie Jilg, MD

Role: primary

[email protected]
+49 8122 959139

Cornelius Waller, MD

Role: primary

[email protected]
+497612700

Martin Bommer, MD

Role: primary

[email protected]
+497161642962

Florian Heidel, MD

Role: primary

[email protected]
+493834 - 86 22006

Dirk Strumberg, MD

Role: primary

[email protected]
+4923234991575

Andreas Hochhaus, MD

Role: primary

[email protected]
03641 ext. 9324216

Christian Langer, MD

Role: primary

[email protected]
+49831530 ext. 2245

Ana Hoffmann, MD

Role: primary

[email protected]
087197403 ext. 429

Madlen Jentzsch, MD

Role: primary

[email protected]
+493419713061

Denise Wolleschak, MD

Role: primary

[email protected]
+4916713134

Andreas Reiter, MD

Role: primary

[email protected]
+496213830

Manfred Hensler, MD

Role: primary

[email protected]
+49621-22430

Juergen Jaeckle, MD

Role: primary

[email protected]
+498331 75049-00

Martin Griesshammer, MD

Role: primary

[email protected]
+495717901184

Holger Hebart, MD

Role: primary

[email protected]
+4971717011397

Jochen Greiner, MD

Role: primary

[email protected]
+497119913517

Ulrike Schwinger, MD

Role: primary

[email protected]
0711-8101-5983

Frank Stegelmann, MD

Role: primary

[email protected]
+49731500 ext. 45928

Julia Glueck-Wolf

Role: primary

[email protected]
+49719559136031

Bjoern Schoettker, MD

Role: primary

[email protected]
+49931322670

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MPN Registry - Ulm

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer
NCT00898079 COMPLETED
Studying Tumor Tissue Samples From Patients With Melanoma Who Have Undergone Sentinel Lymph Node Biopsy
NCT00897481 UNKNOWN
GENomic PROfilation for Therapeutic Purposes in SARComas and Molecular Tumor Board (MTB): Retrospective/Prospective Study in Referral Centers
NCT06076070 UNKNOWN
Myeloproliferative Neoplasms (MPNs) Patient Registry
NCT02760238 RECRUITING
Β3-adrenoreceptor As Prognostic Marker in Neuroblastoma and Ewing Sarcoma
NCT06851221 COMPLETED NA
Detection of Germline and Somatic Pathogenic Variants in Patients With de Novo Metastatic Breast Cancer
NCT05758948 UNKNOWN
UWCCC Molecular Tumor Board Registry
NCT03023202 RECRUITING
Registry of Patients With MPNs in Taiwan
NCT03618485 ACTIVE_NOT_RECRUITING
Biology and Genetics of Smouldering Myeloma
NCT05047107 UNKNOWN
Investigate eNAMPT in Multiple Myeloma Biology and Establish Its Role in Disease Progression
NCT04137523 COMPLETED
Myeloid Mutations Register in R/R CML
NCT05080829 UNKNOWN NA
Establishing a Tumor Registry of Patients With Mesonephric-like Adenocarcinoma (MLA)
NCT06377527 RECRUITING
Familial Investigations of Childhood Cancer Predisposition
NCT03050268 RECRUITING
Evaluation of the Humoral and Tumoral Molecular Alteration Profile of Brain Metastases
NCT05848050 COMPLETED NA
Clinical Cohort of Lymphoma Patients in Malawi
NCT02835911 RECRUITING
Swiss Prospective, Multicenter Study Sentinel Lymph Node Procedure in Colon Cancer
NCT00826579 COMPLETED PHASE1/PHASE2
Microarray Analysis of microRNA Expression in Basal Cell Carcinoma
NCT01498250 COMPLETED
Asian Myeloproliferative Neoplasm (MPN) Registry
NCT05882773 RECRUITING
Micro Assays for HemATology Malignancies Antibody Treatment
NCT07018310 NOT_YET_RECRUITING NA
Perioperative Examination of Inflammatory Markers in Relation to Sentinel Lymph Node Biopsy in Patients With Melanoma; a Pilot Study
NCT05817149 COMPLETED
Registry to Collect Health Information About Desmoplastic Small Round Cell Tumor
NCT04690374 RECRUITING
Clinical Value of Molecular Genetic Analyzes in Gynecological Malignomas
NCT03194347 COMPLETED
Identification and Characterization of Predictive Factors of Onset of Bone Metastases in Cancer Patients
NCT03895216 COMPLETED
Multi-omics Approach of Risk Stratification for Patients With de Novo Acute Myeloid Leukemia
NCT05983172 ENROLLING_BY_INVITATION
Clonal Architecture of ASXL1-mutated Myelofibrosis
NCT05710211 RECRUITING NA